Definitions

1. Unrelated donors are found through the national bone marrow registries. (Web site)

Volunteer Unrelated Donors

1. The remaining seventy percent of patients rely on volunteer unrelated donors.

Results

1. Results of BMT using alternative donors (HLA mismatched related and unrelated donors) have also improved during the last decade.

Analysis

1. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. (Web site)

Survival

1. Overall, the 5-year probability of survival was 87% for transplants using sibling donors, 71% with unrelated donors and 52% with other related donors.
2. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. (Web site)

Related

1. Description: Analysis of 56 patients who underwent allogeneic bone marrow transplant (from related and unrelated donors).

Conditioning

1. Marrow transplants from matched unrelated donors for aplastic anaemia using alemtuzumab, fludarabine and cyclophosphamide based conditioning. (Web site)

Treatment Failure

1. BMT utilizing HLA-matched, unrelated donors carries a high risk of treatment failure along with considerable toxicity. (Web site)

Adults

1. Background Promising results of cord-blood transplants from unrelated donors have been reported in adults.

Cells

1. Cells from other relatives or matched, unrelated donors are sometimes used.

Graft-Versus-Host Disease

1. FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors. (Web site)

Marrow

1. Acute lymphoblastic leukemia (ALL) is the most common indication for transplantation of marrow from unrelated donors in children. (Web site)

Treatment

1. Marrow transplantation from HLA-matched unrelated donors for treatment of hematologic malignancies.
2. Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. (Web site)

Outcome

1. Outcome of 125 children with chronic myelogenous leukemia who received transplants from unrelated donors: the Japan Marrow Donor Program.
2. Outcome of cord-blood transplantation from related and unrelated donors.

Siblings

1. In allogeneic HSCT, HSCs are collected from related (HLA-matched) siblings or matched unrelated donors.

Sibling

1. Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors. (Web site)

Bone Marrow

1. No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors.

Recipients

1. For other recipients, registries of volunteer unrelated donors can be quickly searched in order to find a potential HLA match. (Web site)

Transplantation

1. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. (Web site)
2. Active protocols exist for transplantation with bone marrow, peripheral blood stem cells, and umbilical cord blood from related as well as unrelated donors.
3. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. (Web site)

Allogeneic Bone Marrow Transplantation

1. Allogeneic bone marrow transplantation using unrelated donors: a pilot study of the Canadian Bone Marrow Transplant Group.

Patients

1. Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure. (Web site)
2. Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation. (Web site)
3. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.

Chronic Myeloid Leukemia

1. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors.

Graft Failure

1. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors.

Gvhd

1. Rates of GVHD vary from between 30-40% among related donors and recipients to 60-80% between unrelated donors and recipients.

Stem Cells

1. The 61 "unmatched" patients received stem cells from alternative donors, for instance, other relatives (9 patients) or unrelated donors (52 patients). (Web site)
2. Older people, people who have had acute GVHD before, and people who received stem cells from mismatched or unrelated donors are more likely to develop GVHD. (Web site)

Transplants

1. Patients lacking such HLA-identical sibling donors must receive transplants from more distant relatives or from unrelated donors. (Web site)
2. Stem cells from cord blood from both related and unrelated donors have been successful in many transplants. (Web site)
3. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. (Web site)

Immunosuppressive Therapy

1. Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy. (Web site)
2. He also describes the results in patients with aplastic anemia given HCT from unrelated donors after failure of responding to immunosuppressive therapy.
3. Patients in whom immunosuppressive therapy fails have later undergone successful transplantation from matched siblings or from unrelated donors.

Bone Marrow Transplant

1. Bone marrow transplant from unrelated donors for patients with chronic myeloid leukemia.

Bone Marrow Transplants

1. Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.
2. Factors influencing the outcome of bone marrow transplants using unrelated donors. (Web site)
3. Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia. (Web site)

Unrelated Donors

1. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy. (Web site)
2. Transplantation of these cells from unrelated donors is a treatment option frequently offered to patients after failed immunosuppressive therapy.
3. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. (Web site)

Categories

1. Bone Marrow Transplants
2. Immunosuppressive Therapy
3. Gvhd
4. Chronic Myeloid Leukemia
5. Marrow Transplantation
6. Books about "Unrelated Donors" in Amazon.com
   

Continue: More Keywords - - - - - - - - - -